Patents by Inventor Barry Hubertus Gerardus ROCKX

Barry Hubertus Gerardus ROCKX has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SARS-COV-2(SARS2, COVID-19) ANTIBODIES
    Publication number: 20220017606
    Abstract: The invention relates to antibodies and antigen-binding fragments thereof that recognize SARS-Cov-2 spike proteins (SARS2-S). In some embodiments, the antibodies bind to SARS2-S with high affinity and/or inhibit SARS-Cov-2 infection of human cells. in some embodiments, the antibodies provide a means of preventing, treating or ameliorating SARS2 infection, In some embodiments, the antibodies are used in diagnostic assays (e.g. serodiagnostic assays for SARS2).
    Type: Application
    Filed: July 20, 2021
    Publication date: January 20, 2022
    Inventors: Franklin Gerardus Grosveld, Dubravka Drabek, Rien Van Haperen, Berend Jan Bosch, Juliette Fedry, Daniel L. Hurdiss, Thijs Kuiken, Batholomeus Leonardus Haagmans, Barry Hubertus Gerardus Rockx
  • SARS-COV-2 (SARS2, COVID-19) ANTIBODIES
    Publication number: 20210340225
    Abstract: The invention relates to antibodies and antigen-binding fragments thereof that recognize SARS-Cov-2 spike proteins (SARS2-S). In some embodiments, the antibodies bind to SARS2-S with high affinity and/or inhibit SARS-Cov-2 infection of human cells. In some embodiments, the antibodies provide a means of preventing, treating or ameliorating SARS2 infection. In some embodiments, the antibodies are used in diagnostic assays (e.g. serodiagnostic assays for SARS2).
    Type: Application
    Filed: March 5, 2021
    Publication date: November 4, 2021
    Inventors: Franklin Gerardus Grosveld, Dubravka Drabek, Rien van Haperen, Berend Jan Bosch, Juliette Fedry, Daniel L. Hurdiss, Thijs Kuiken, Batholomeus Leonardus Haagmans, Barry Hubertus Gerardus Rockx
  • TREATMENTS AND BIOMARKERS FOR THE PROGNOSIS OF ZIKA VIRUS INFECTION
    Publication number: 20210148936
    Abstract: The disclosure provides methods, biomarkers, and kits for determining the prognosis of Zika virus infection in relation to severity of symptoms resulting from effects of the Zika virus infection on bone metabolism, such as arthralgia, osteoporosis, and craniosynostosis. The disclosure further provides treatments for Zika virus infection, in particular for treating arthralgia, osteoporosis, and craniosynostosis.
    Type: Application
    Filed: May 15, 2019
    Publication date: May 20, 2021
    Inventors: Barry Hubertus Gerardus ROCKX, Bram Cornelis Jeroen VAN DER EERDEN, Maria Petronella Gerarda KOOPMANS, Johannes Petrus Thomas Maria VAN LEEUWEN